Skip to main content
. 2019 Feb 27;10:71–84. doi: 10.2147/JBM.S190784

Figure 1.

Figure 1

Structure of rituximab, a chimeric monoclonal antibody (~30% mouse origin and ~70% human origin).

Notes: The murine variable regions bind specifically to the CD20 antigen on malignant (as well as normal) B cells. The human constant regions allow human effector mechanisms.

Abbreviations: VL, variable domain (light chain); VH, variable domain (heavy chain); CL, constant domain (light chain); CH, constant domain (heavy chain).